ITGAM and neoplasm: For instance, cancer cells that overexpress CXCL1 and 2 were found to be more primed for survival at metastatic sites, and are capable of attracting CD11b(+)Gr1(+) myeloid cells into the tumor that enhance cancer cell survival and enhance their chemoresistance and metastatic ability[47].